Skip to main content
. Author manuscript; available in PMC: 2021 Nov 9.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Feb 1;83(2):135–139. doi: 10.1097/QAI.0000000000002244

FIGURE 1.

FIGURE 1.

Residual drug level in returned rings for each participant through the course of study participation. The solid line represents 23.5 mg.